AI Assistant

Cardiolipin Antibodies

Autoimmune Tests
108.00

Private Cardiolipin Antibodies testing in London for £108, assessing one antiphospholipid antibody marker with results in around 2 days.

Turnaround time

2 business days

Biomarkers count

1

Reordering your previous test
We've pre-selected your previous add-ons ({{ selectedAddOns.length }}). You can still remove any or add new ones. Pick your clinic and time — the rest is set from your last order.
Enhance Your Panel
{{ availableAddOns.length }} extra tests · sorted by relevance
×
No tests match "{{ addOnSearch }}"
{{ selectedAddOns.length }} test{{ selectedAddOns.length !== 1 ? 's' : '' }} added +£{{ addOnsTotal.toFixed(2) }}
Same-Day Appointments
UKAS Accredited Labs

Book your test

Under 18? Patients under 18 can only be seen at GB Medlabs and Clinilabs, Monday to Friday only.
1
Email
2
Service
3
Details
4
Confirm
{{ emailError }}
Choose Service Type
Home visit

Professional phlebotomist comes to you

+ £{{ home_visit_fee }}

In clinic

Visit our clinic for your test

{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}

Home Visit Details
{{ homeAddressError }}

Home visits require at least 24 hours notice.

{{ homeTimeError }}
Note: Home visits are not available on Sundays
Select a clinic: Sorting by distance…
{{ clinic.name }}

{{ clinicAddress(clinic) }}

{{ clinic.distance.toFixed(1) }} mi
{{ selectedClinic.name }}

{{ clinicAddress(selectedClinic) }}

Select a date
{{ timeSlotAlert }}
Note: Bookings are not available on Sundays
Select an hour

Available time slots: {{ timeSlots.length}}

{{ selectedAddOns.length }} extra test{{ selectedAddOns.length !== 1 ? 's' : '' }} added +£{{ addOnsTotal.toFixed(2) }}
Please confirm your consent before proceeding.

Overview of the Cardiolipin Antibodies Test

The Cardiolipin Antibodies blood test detects antibodies directed against phospholipid-associated structures, providing important information during investigation of antiphospholipid syndrome.

The test assesses 1 specialist autoimmune marker: Cardiolipin Antibodies.

Antiphospholipid syndrome, commonly abbreviated to APS and sometimes called Hughes syndrome, is an autoimmune condition associated with an increased tendency to form blood clots and with selected pregnancy complications.

Cardiolipin Antibodies are one of the principal laboratory markers used when APS is being investigated.

The assay commonly assesses IgG and IgM Cardiolipin Antibodies.

However, one positive result does not diagnose antiphospholipid syndrome.

Antiphospholipid antibodies can appear temporarily following infections or other inflammatory events.

For this reason, persistent positivity is important.

Where APS is suspected, a positive result is generally repeated after at least 12 weeks to establish whether the antibody remains present.

The clinical history is equally important.

APS diagnosis requires an appropriate clinical event, such as objectively documented thrombosis or recognised pregnancy morbidity, together with relevant persistent laboratory findings.

Other important APS investigations include Lupus Anticoagulant and Beta-2 Glycoprotein I Antibodies.

Cardiolipin Antibodies can also occur in systemic lupus erythematosus and selected other autoimmune conditions.

The antibody concentration and class are relevant because low-level transient positivity can have different significance from persistent moderate or high antibody levels.

What Does the Cardiolipin Antibodies Test Check?

The test detects Cardiolipin Antibodies associated with antiphospholipid autoimmunity and increased thrombotic or obstetric risk in the appropriate clinical setting. This test measures 1 specialist biomarker.

Antiphospholipid Antibodies
Cardiolipin Antibodies

Detects antiphospholipid antibodies directed against cardiolipin-associated complexes, supporting assessment of antiphospholipid syndrome when interpreted alongside clinical history and other APS markers.

Who May Benefit From the Cardiolipin Antibodies Test?

Cardiolipin Antibodies testing can be useful where unexplained thrombosis, defined pregnancy complications or antiphospholipid syndrome are being investigated.

People with an unexplained deep vein thrombosis - Antiphospholipid antibodies can contribute to acquired thrombophilia.

People with an unexplained pulmonary embolism - APS can increase venous clotting risk.

People with selected arterial thrombosis or stroke at a younger age - Antiphospholipid antibody testing may form part of specialist investigation.

People with recurrent pregnancy loss under specialist assessment - APS is one recognised autoimmune cause of selected recurrent pregnancy complications.

People with defined placental pregnancy complications - Persistent antiphospholipid antibodies can affect placental circulation.

People with systemic lupus erythematosus - Cardiolipin Antibodies occur more frequently in people with lupus.

People with a previous positive Cardiolipin Antibody result - Repeat testing after an appropriate interval can establish whether positivity persists.

People referred for antiphospholipid syndrome investigation - Cardiolipin testing is usually interpreted with Lupus Anticoagulant and Beta-2 Glycoprotein I antibodies.

How to Prepare

Fasting
Fasting is not required.
Hydration
Drink water normally before the appointment.
Medication
Continue prescribed medication unless your clinician advises otherwise.
Anticoagulants
Record Warfarin, Heparin, Apixaban, Rivaroxaban or other anticoagulant treatment even though Cardiolipin Antibodies themselves are antibody measurements.
Recent infection
Record significant recent infection because temporary Cardiolipin Antibody positivity can occur.
Thrombosis history
Provide the date and type of any previous DVT, pulmonary embolism, stroke or arterial thrombosis.
Pregnancy history
Provide information about recurrent pregnancy loss or significant placental complications where relevant.
Previous APS results
Keep previous Cardiolipin, Lupus Anticoagulant and Beta-2 Glycoprotein I results where available.

Do not stop anticoagulant treatment independently.

Where an initial Cardiolipin Antibody result is positive, repeat testing after at least 12 weeks may be required to establish persistent positivity.

Symptoms and Reasons to Consider the Cardiolipin Antibodies Test

Cardiolipin Antibodies themselves do not produce a specific symptom pattern. Testing is prompted by clinical events associated with antiphospholipid syndrome.

An unexplained DVT - Persistent antiphospholipid antibodies can increase venous thrombosis risk.

An unexplained pulmonary embolism - APS may be considered when clotting occurs without a clear provoking factor.

Stroke or arterial thrombosis at an unexpectedly young age - Autoimmune thrombophilia can be part of the differential diagnosis.

Recurrent pregnancy loss - Selected pregnancy histories can meet clinical criteria relevant to APS assessment.

Significant placental pregnancy complications - Antiphospholipid antibodies can affect placental blood flow.

A previous positive Lupus Anticoagulant result - Cardiolipin Antibodies can provide complementary APS information.

Systemic lupus erythematosus with clotting concerns - APS can occur independently or alongside lupus.

A previous positive Cardiolipin result - Repeat testing can establish whether the finding is persistent or temporary.

A positive Cardiolipin Antibody result does not independently diagnose antiphospholipid syndrome.

Persistent positivity and an appropriate clinical history are required.

Sudden chest pain, shortness of breath, coughing blood, unilateral leg swelling, facial weakness or other symptoms of an acute clot or stroke require emergency medical assessment.

How to Book Your Cardiolipin Antibodies Test

The Cardiolipin Antibodies test can be booked privately for specialist investigation of antiphospholipid autoimmunity.

1
Choose the Cardiolipin Antibodies

Select the individual Cardiolipin Antibodies blood test online.

2
Select your sample collection option

Choose an in-clinic blood draw or professional home or hotel phlebotomy where suitable.

3
Attend your appointment

A trained healthcare professional collects the required venous blood sample and relevant clotting or pregnancy history can be documented.

4
Laboratory analysis

Your serum undergoes specialist measurement of Cardiolipin Antibodies.

5
Receive your results securely

Your authorised result is delivered securely and can be interpreted alongside Lupus Anticoagulant and other APS markers where appropriate.

When Will I Receive My Results?

The specialist laboratory turnaround for Cardiolipin Antibodies is approximately 2 days after laboratory receipt.

This is a specialist immunology assay.

The sample undergoes antibody analysis, quality-control procedures and result authorisation.

Turnaround begins when the specimen reaches the laboratory rather than necessarily from the exact time the blood sample is collected.

Any repeat test required after at least 12 weeks to demonstrate persistent positivity is a separate episode of testing.

Understanding Your Results

The laboratory may report Cardiolipin Antibodies according to antibody class and concentration.

A negative result means clinically significant Cardiolipin Antibodies were not detected according to the assay threshold.

This reduces the likelihood of this particular APS laboratory marker but does not exclude Lupus Anticoagulant or Beta-2 Glycoprotein I Antibodies.

A positive result means measurable Cardiolipin Antibodies are present.

The significance depends on the concentration, antibody class and whether the result persists.

Low-level positivity can occur temporarily, particularly after infection.

Persistent moderate or high antibody levels are generally more clinically relevant in the appropriate clinical setting.

APS is not diagnosed from laboratory antibodies alone.

A relevant history of thrombosis or recognised pregnancy morbidity and repeat demonstration of antibody persistence are important.

The result should therefore be interpreted by a clinician familiar with thrombosis or autoimmune disease.

Why Book With London Blood Tests?

London Blood Tests provides private access to Cardiolipin Antibody testing for antiphospholipid syndrome assessment.

Measures a principal APS antibody - Cardiolipin Antibodies are among the recognised laboratory markers used in antiphospholipid syndrome assessment.

Relevant to unexplained thrombosis - Persistent antibodies can be associated with increased venous or arterial clotting risk.

Relevant to selected pregnancy complications - APS can contribute to defined recurrent pregnancy and placental problems.

Can complement Lupus Anticoagulant - Combined testing provides a broader antiphospholipid assessment.

Relevant to people with lupus - Cardiolipin Antibodies are more common in systemic lupus erythematosus.

Specialist laboratory analysis - Samples undergo dedicated autoimmune antibody measurement.

Professional blood collection - Clinic and suitable home or hotel phlebotomy appointments are available.

Clear pricing - The Cardiolipin Antibodies test costs £108.

Private Cardiolipin Antibodies Blood Test in London

London Blood Tests provides private Cardiolipin Antibodies testing for people requiring investigation of antiphospholipid autoimmunity.

The test costs £108 and assesses 1 specialist biomarker.

Results are expected approximately 2 days after laboratory receipt.

The result should be interpreted alongside the clinical history and other antiphospholipid tests rather than used alone to diagnose APS.

Frequently Asked Questions

They are antiphospholipid autoantibodies associated with antiphospholipid syndrome and an increased risk of selected thrombotic and pregnancy complications.

APS is an autoimmune condition characterised by persistent antiphospholipid antibodies together with relevant clinical events such as thrombosis or defined pregnancy morbidity.

No. The result must be interpreted with clinical criteria and persistent antibody positivity.

Temporary Cardiolipin Antibodies can occur, particularly following infection, so persistence needs to be demonstrated when APS is being assessed.

Yes. Antiphospholipid antibodies occur more frequently in people with systemic lupus erythematosus.

Lupus Anticoagulant and Beta-2 Glycoprotein I Antibodies provide complementary information.

Persistent clinically significant antiphospholipid antibodies can be associated with defined pregnancy complications as part of APS.

No.

No. Do not stop prescribed anticoagulants unless the clinician responsible for your treatment specifically instructs you to do so.

Results are expected approximately 2 days after laboratory receipt.
+44 203 488 0809 WhatsApp